Effect of switching of anti-VEGF drug in nAMD, real-life data from the Dutch FRB! registry

被引:0
|
作者
Ponsioen, Th. L. [1 ]
Tigchelaar-Besling, O. A. M. [2 ]
Klaver, C. C. W. [3 ]
Gillies, M. C. [4 ]
Nguyen, V. [4 ]
Barthelmes, D. [5 ]
Verbraak, F. D. [6 ]
机构
[1] Isala Clin, Dept Ophthalmol, Zwolle, Netherlands
[2] Amphia Clin, Dept Ophthalmol, Breda, Netherlands
[3] Radboud Univ Med Clin, Dept Ophthalmol, Nijmegen, Netherlands
[4] Univ Sydney, Save Sight Inst, Sydney Med Sch, Sydney, NSW, Australia
[5] Univ Hosp Zurich, Dept Ophthalmol, Zurich, Switzerland
[6] Univ Amsterdam, Dept Ophthalmol, Med Ctr, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:32 / 33
页数:2
相关论文
共 50 条
  • [1] Real-life results of anti-VEGF treatment in fellow eyes with nAMD
    Deiters, V.
    Vogt, D.
    Guenther, S. R.
    Kortuem, K.
    Wolf, A.
    Priglinger, S. G.
    Schumann, R. G.
    [J]. OPHTHALMOLOGE, 2022, 119 (03): : 272 - 279
  • [2] Real-life results of anti-VEGF treatment in fellow eyes with nAMD
    Deiters, V.
    Vogt, D.
    Guenther, S. R.
    Kortuem, K.
    Wolf, A.
    Priglinger, S. G.
    Schumann, R. G.
    [J]. OPHTHALMOLOGIE, 2022, 119 (03): : 272 - 279
  • [3] Editorial: Real-Life Data of Anti-VEGF Therapy
    Wilke, Robert
    Finger, Robert
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2017, 234 (12) : 1449 - 1450
  • [4] Real-life-Ergebnisse der Anti-VEGF-Therapie bei nAMD der PartneraugenReal-life results of anti-VEGF treatment in fellow eyes with nAMD
    V. Deiters
    D. Vogt
    S. R. Guenther
    K. Kortuem
    A. Wolf
    S. G. Priglinger
    R. G. Schumann
    [J]. Der Ophthalmologe, 2022, 119 (3): : 272 - 279
  • [5] The Real World Effect of Anti-VEGF Injections on IOP Using the IRIS Registry
    Atchison, Elizabeth Anne
    Barry, Catherine N.
    Lum, Flora
    Mattox, Cynthia
    MacCumber, Mathew W.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [6] Registry data from Sweden Real-life data on urticaria
    Lux, Sebastian
    [J]. ALLERGO JOURNAL, 2022, 31 (05) : 8 - 8
  • [7] Comparison of anti-VEGF ranibizumabR and afliberceptR : a 18 months, real-life study in naive patients
    George, Arnaud
    Reitzer, Valerie
    Bellamy, Jean Paul
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Neovascular glaucoma in patients with central retinal vein occlusion: A real-life study in the anti-VEGF era
    Casselholm de Salles, Manuel
    Lindberg, Charlotte
    Epstein, David
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (01) : E7 - E12
  • [9] Anti-VEGF preserves quality of life - results from the ALBATROS real-world data collection from Germany
    Wolfram, Christian
    Pfeiffer, Norbert
    Hudde, Tobias
    Klatt, Alexander
    Schnegelsberg, Birthe
    Midani-Oezkan, Heven
    Ziemssen, Focke
    Schuster, Alexander
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [10] Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry
    Biscaglia, Simone
    Campo, Gianluca
    Pavasini, Rita
    Tebaldi, Matteo
    Tumscitz, Carlo
    Ferrari, Roberto
    [J]. PLATELETS, 2016, 27 (05) : 484 - 487